Iovance Biotherapeutics to build $75M facility in Philadelphia

Iovance Biotherapeutics has entered into a lease agreement to build a 136,000 square foot commercial-scale production facility at the Philadelphia Navy Yard for TIL cancer therapies. The company expects to invest approximately $75 million over three years and create several hundred jobs.

“Building our own internal production capabilities will help us reduce the cost of operations which is necessary for offering broad access to TIL therapy.”globenewswire.com

• 1 source
• globenewswire.comIovance Biotherapeutics Announces New Facility to SupportIovance Biotherapeutics, Inc.May 29, 2019

Summarized from public sources; check the original articles before acting on it.